Price movement over the last 24 hours
ACADIA Pharmaceuticals Inc. vs Banco Santander SA — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while Banco Santander SA trades at $13.6 (market cap $203.67B). The key difference: Banco Santander SA is far larger — about 45.4× ACADIA Pharmaceuticals Inc.'s market cap, and Banco Santander SA pays a 1.96% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | SAN | |
|---|---|---|
Market Cap | $4.49B | $203.67B |
Sector | Health | Financials |
52-Week High | $28.06 | $14.37 |
52-Week Low | $20.06 | $8.31 |
Enterprise Value | $3.69B | — |
Dividend Yield | — | 1.96% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →